278 related articles for article (PubMed ID: 18782852)
1. Alterations in the expression, structure and function of progesterone receptor membrane component-1 (PGRMC1) in premature ovarian failure.
Mansouri MR; Schuster J; Badhai J; Stattin EL; Lösel R; Wehling M; Carlsson B; Hovatta O; Karlström PO; Golovleva I; Toniolo D; Bione S; Peluso J; Dahl N
Hum Mol Genet; 2008 Dec; 17(23):3776-83. PubMed ID: 18782852
[TBL] [Abstract][Full Text] [Related]
2. Progesterone receptor membrane component-1 (PGRMC1) is the mediator of progesterone's antiapoptotic action in spontaneously immortalized granulosa cells as revealed by PGRMC1 small interfering ribonucleic acid treatment and functional analysis of PGRMC1 mutations.
Peluso JJ; Romak J; Liu X
Endocrinology; 2008 Feb; 149(2):534-43. PubMed ID: 17991724
[TBL] [Abstract][Full Text] [Related]
3. Analysis of progesterone receptor membrane component 1 mutation in Han Chinese women with premature ovarian failure.
Wang JL; Li SL; Qin YY; Chen ZJ
Reprod Biomed Online; 2014 Nov; 29(5):640-3. PubMed ID: 25246111
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of progesterone receptor membrane component 1 (PGRMC1) in peripheral nucleated blood cells associated with premature ovarian failure (POF) and polycystic ovary syndrome (PCOS).
Schuster J; Karlsson T; Karlström PO; Poromaa IS; Dahl N
Reprod Biol Endocrinol; 2010 Jun; 8():58. PubMed ID: 20537145
[TBL] [Abstract][Full Text] [Related]
5. Progesterone receptor membrane component 1 (PGRMC1) binds and stabilizes cytochromes P450 through a heme-independent mechanism.
McGuire MR; Mukhopadhyay D; Myers SL; Mosher EP; Brookheart RT; Kammers K; Sehgal A; Selen ES; Wolfgang MJ; Bumpus NN; Espenshade PJ
J Biol Chem; 2021 Nov; 297(5):101316. PubMed ID: 34678314
[TBL] [Abstract][Full Text] [Related]
6. Spectroscopic and mutagenesis studies of human PGRMC1.
Kaluka D; Batabyal D; Chiang BY; Poulos TL; Yeh SR
Biochemistry; 2015 Mar; 54(8):1638-47. PubMed ID: 25675345
[TBL] [Abstract][Full Text] [Related]
7. Regulation of ovarian cancer cell viability and sensitivity to cisplatin by progesterone receptor membrane component-1.
Peluso JJ; Liu X; Saunders MM; Claffey KP; Phoenix K
J Clin Endocrinol Metab; 2008 May; 93(5):1592-9. PubMed ID: 18319313
[TBL] [Abstract][Full Text] [Related]
8. Progesterone signaling mediated through progesterone receptor membrane component-1 in ovarian cells with special emphasis on ovarian cancer.
Peluso JJ
Steroids; 2011 Aug; 76(9):903-9. PubMed ID: 21371489
[TBL] [Abstract][Full Text] [Related]
9. Progesterone receptor membrane component 1 modulates human cytochrome p450 activities in an isoform-dependent manner.
Oda S; Nakajima M; Toyoda Y; Fukami T; Yokoi T
Drug Metab Dispos; 2011 Nov; 39(11):2057-65. PubMed ID: 21825115
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronic acid promotes the expression of progesterone receptor membrane component 1 via epigenetic silencing of miR-139-5p in human and rat granulosa cells.
Zhao G; Zhou X; Fang T; Hou Y; Hu Y
Biol Reprod; 2014 Nov; 91(5):116. PubMed ID: 25232020
[TBL] [Abstract][Full Text] [Related]
11. S2R(Pgrmc1): the cytochrome-related sigma-2 receptor that regulates lipid and drug metabolism and hormone signaling.
Ahmed IS; Chamberlain C; Craven RJ
Expert Opin Drug Metab Toxicol; 2012 Mar; 8(3):361-70. PubMed ID: 22292588
[TBL] [Abstract][Full Text] [Related]
12. PGRMC1 (progesterone receptor membrane component 1): a targetable protein with multiple functions in steroid signaling, P450 activation and drug binding.
Rohe HJ; Ahmed IS; Twist KE; Craven RJ
Pharmacol Ther; 2009 Jan; 121(1):14-9. PubMed ID: 18992768
[TBL] [Abstract][Full Text] [Related]
13. The emerging role of progesterone receptor membrane component 1 (PGRMC1) in cancer biology.
Cahill MA; Jazayeri JA; Catalano SM; Toyokuni S; Kovacevic Z; Richardson DR
Biochim Biophys Acta; 2016 Dec; 1866(2):339-349. PubMed ID: 27452206
[TBL] [Abstract][Full Text] [Related]
14. Dap1/PGRMC1 binds and regulates cytochrome P450 enzymes.
Hughes AL; Powell DW; Bard M; Eckstein J; Barbuch R; Link AJ; Espenshade PJ
Cell Metab; 2007 Feb; 5(2):143-9. PubMed ID: 17276356
[TBL] [Abstract][Full Text] [Related]
15. In vitro inhibition of SKOV-3 cell migration as a distinctive feature of progesterone receptor membrane component type 2 versus type 1.
Albrecht C; Huck V; Wehling M; Wendler A
Steroids; 2012 Dec; 77(14):1543-50. PubMed ID: 23064006
[TBL] [Abstract][Full Text] [Related]
16. Progesterone receptor membrane component 1 inhibits the activity of drug-metabolizing cytochromes P450 and binds to cytochrome P450 reductase.
Szczesna-Skorupa E; Kemper B
Mol Pharmacol; 2011 Mar; 79(3):340-50. PubMed ID: 21081644
[TBL] [Abstract][Full Text] [Related]
17. Progesterone inhibits apoptosis in part by PGRMC1-regulated gene expression.
Peluso JJ; Liu X; Gawkowska A; Lodde V; Wu CA
Mol Cell Endocrinol; 2010 May; 320(1-2):153-61. PubMed ID: 20144686
[TBL] [Abstract][Full Text] [Related]
18. Premature ovarian failure.
Beck-Peccoz P; Persani L
Orphanet J Rare Dis; 2006 Apr; 1():9. PubMed ID: 16722528
[TBL] [Abstract][Full Text] [Related]
19. Progesterone membrane receptor component 1 expression in the immature rat ovary and its role in mediating progesterone's antiapoptotic action.
Peluso JJ; Pappalardo A; Losel R; Wehling M
Endocrinology; 2006 Jun; 147(6):3133-40. PubMed ID: 16513825
[TBL] [Abstract][Full Text] [Related]
20. Premature ovarian failure, absence of pubic and axillary hair with de novo 46,X,t(X;15)(q24;q26.3).
Giacomozzi C; Gullotta F; Federico G; Colapietro I; Nardone AM; Cianfarani S
Am J Med Genet A; 2010 May; 152A(5):1305-9. PubMed ID: 20425841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
